Zydus commences trial to generate data on effect of Saroglitazar Mg in NAFLD patients
The "Phase IV EVIDENCES- XI" trial will enrol around 1,500 male and female NAFLD patients with comorbidities (either obesity, type 2 diabetes mellitus, dyslipidemia or metabolic syndrome- 200 patients each), the drug maker said in a regulatory filing.
)
Zydus Lifesciences on Friday said it has commenced Phase IV real world data registry trial to ascertain the benefits of Saroglitazar Magnesium in non-alcoholic fatty liver disease (NAFLD) patients with comorbidities.
The "Phase IV EVIDENCES- XI" trial will enrol around 1,500 male and female NAFLD patients with comorbidities (either obesity, type 2 diabetes mellitus, dyslipidemia or metabolic syndrome- 200 patients each), the drug maker said in a regulatory filing.
The study duration is around 56 weeks, it added.
TRENDING NOW
The primary endpoint is to measure the change in liver stiffness from baseline to 52nd week, it said.
Rohit Loomba, MD, Professor of Medicine, Division Chief of Gastroenterology at University of California, San Diego School of Medicine and Director of Hepatology at UC San Diego Health will lead the steering committee of the trial, Zydus said.
"It will help generate novel real world data in NAFLD/NASH patients that is especially lacking in Asian populations. Real world data is crucial to formulate clinical guidelines, to further support its use in clinical practice," Loomba said.
Zydus Lifesciences Chairman Pankaj R Patel said the company has now studied Saroglitazar Mg in over 10 different trials.
"We hope that this (latest trial) will be a big leap forward in managing and treating the unmet healthcare needs of NAFLD and nonalcoholic steatohepatitis, (NASH)," he added.
The second Phase III study of Saroglitazar Mg in NAFLD patients demonstrated that treatment with Saroglitazar Mg had a beneficial effect on primary end-point of change in liver fat content.
Zydus Lifesciences shares were trading 0.86 per cent down at Rs 508.65 apiece on the BSE.
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
03:30 pm
Zydus Lifesciences shares extend losses to third day; is there any opportunity?
USFDA gives nod to Zydus Lifesciences for generic rheumatoid arthritis treatment drug 
Zydus gets USFDA nod to market cancer treatment generic injection
Zydus Lifesciences gets USFDA nod for generic acne-treating drug
Zydus gets USFDA nod for generic drug to treat stomach & esophagus problems
